A new procedure for sickle cell disease is showing great promise at essentially reversing the condition by altering the genetic code of the cells.
In a French trial, a teenage patient in had their bone marrow removed and infected by an engineered virus that inserted the correct genetic instructions into the DNA. On return, the marrow began to produce only normal red blood cells and has continued to do so for the past 15 months – during which he has required minimal treatment.
Similar companion trials are soon to be established in the US and may then be applied to less-developed countries which are most affected by this condition but lack the funding and technology required by this procedure.
Read more at: http://www.bbc.com/news/health-39142971